Management tracks: Calico, Apellis, Immutep

Calico Life Sciences LLC (South San Francisco, Calif.) hired Aarif Khakoo as its first head of drug development. He will lead the company’s early stage development from candidate selection through Phase II. Khakoo was VP and head of translational medicine, global development at Amgen Inc. (NASDAQ:AMGN). Calico focuses on aging research and therapies targeting age-related diseases.

Autoimmune company Apellis Pharmaceuticals Inc. (NASDAQ:APLS) hired Thomas Lackner as SVP, head of Europe, a newly created role. Lackner was VP head of European commercial operations for Prothena Corp. plc (NASDAQ:PRTA)...